SCHEMBL12817618

SCHEMBL12817618

Cc1nc2cc(S(=O)(=O)N3CCOc4ccc(-c5cnco5)cc43)ccc2o1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.41
▸ KMT2A Q03164 5/20 0.41
▸ CYP2C9 P11712 1/20 0.40
▸ MAPT P10636 3/20 0.38
▸ TP53 P04637 1/20 0.38
▸ PDE3B Q13370 4/20 0.36
▸ PDE3A Q14432 4/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ GCK P35557 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.34
▸ CYP3A4 P08684 2/20 0.34
▸ CYP2D6 P10635 2/20 0.34
▸ IMPDH2 P12268 1/20 0.34
▸ CPT1A P50416 1/20 0.34
▸ CPT1B Q92523 1/20 0.34
▸ PSEN1 P49768 1/20 0.34
▸ PSEN2 P49810 1/20 0.34
▸ APH1B Q8WW43 1/20 0.34
▸ NCSTN Q92542 1/20 0.34
▸ APH1A Q96BI3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12818293 0.83 CPT2 (0.35) MEN1KMT2AMAPTGCKALDH1A1
SCHEMBL12818652 0.83 MEN1 (0.40) MEN1KMT2ACYP2C9MAPTTP53
SCHEMBL12818134 0.82 CYP2C9 (0.40) MEN1KMT2ACYP2C9MAPTTP53
SCHEMBL12817846 0.82 LMNA (0.43) MEN1KMT2ACYP2C9MAPTTP53
SCHEMBL12818382 0.81 MAPT (0.44) MEN1KMT2ACYP2C9MAPTTP53
SCHEMBL12819192 0.80 MEN1 (0.40) MEN1KMT2ACYP2C9MAPTTP53
SCHEMBL12818698 0.79 CYP2C9 (0.37) MEN1KMT2ACYP2C9MAPTTP53
SCHEMBL12817667 0.79 PGR (0.39) MEN1KMT2ACYP2C9MAPTTP53
SCHEMBL12817769 0.79 CYP2C9 (0.38) MEN1KMT2ACYP2C9MAPTTP53
SCHEMBL12818506 0.78 CYP2C9 (0.42) MEN1KMT2ACYP2C9MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO disclosed
Send feedback